• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激素替代疗法在绝经后2型糖尿病女性中的应用。

The use of hormone replacement therapy in postmenopausal women with type 2 diabetes.

作者信息

Cefalu W T

机构信息

Endocrine, Diabetes, and Metabolism Unit, Department of Medicine, University of Vermont College of Medicine, One South Prospect Street, Burlington, VT 05401, USA.

出版信息

J Womens Health Gend Based Med. 2001 Apr;10(3):241-55. doi: 10.1089/152460901300139998.

DOI:10.1089/152460901300139998
PMID:11389784
Abstract

In healthy postmenopausal women, estrogen or hormone replacement therapy (ERT or HRT) can alleviate menopausal symptoms and prevent osteoporosis and may also protect against cardiovascular disease (CVD). In addition to improving lipid metabolism, there are reports that estrogen also improves parameters regulating carbohydrate metabolism, including insulin resistance, in healthy women. Therefore, it is likely that ERT or HRT would also benefit women with type 2 diabetes, not only in relieving menopausal symptoms but also in improving the metabolic abnormalities associated with diabetes and in preventing cardiovascular disease.

摘要

在健康的绝经后女性中,雌激素或激素替代疗法(ERT或HRT)可以缓解更年期症状、预防骨质疏松症,还可能预防心血管疾病(CVD)。除了改善脂质代谢外,有报道称雌激素还能改善调节碳水化合物代谢的参数,包括健康女性的胰岛素抵抗。因此,ERT或HRT可能也会使2型糖尿病女性受益,不仅能缓解更年期症状,还能改善与糖尿病相关的代谢异常以及预防心血管疾病。

相似文献

1
The use of hormone replacement therapy in postmenopausal women with type 2 diabetes.激素替代疗法在绝经后2型糖尿病女性中的应用。
J Womens Health Gend Based Med. 2001 Apr;10(3):241-55. doi: 10.1089/152460901300139998.
2
Benefits of hormone replacement therapy in postmenopausal women.绝经后女性激素替代疗法的益处。
J Am Acad Nurse Pract. 2007 Dec;19(12):635-41. doi: 10.1111/j.1745-7599.2007.00269.x.
3
Menopausal hormone replacement therapy.更年期激素替代疗法
Curr Womens Health Rep. 2003 Oct;3(5):410-7.
4
Perspectives on the Women's Health Initiative trial of hormone replacement therapy.关于女性健康倡议激素替代疗法试验的观点
Obstet Gynecol. 2002 Dec;100(6):1344-53. doi: 10.1016/s0029-7844(02)02503-6.
5
Menopause and hormone replacement therapy.更年期与激素替代疗法。
Med Clin North Am. 1998 Mar;82(2):297-320. doi: 10.1016/s0025-7125(05)70608-8.
6
The SOGC statement on the WHI report on estrogen and progestin use in postmenopausal women.加拿大妇产科医师协会关于美国国立卫生研究院妇女健康倡议(WHI)绝经后妇女使用雌激素和孕激素报告的声明。
J Obstet Gynaecol Can. 2002 Oct;24(10):783-90, 793-802. doi: 10.1016/s1701-2163(16)30471-6.
7
Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.更年期医学:欧洲更年期与男性更年期协会(EMAS)2004/2005年关于围绝经期和绝经后激素替代疗法的立场声明。
Maturitas. 2005 May 16;51(1):8-14. doi: 10.1016/j.maturitas.2005.02.019.
8
What you should know about hormone therapy health risks and benefits.关于激素疗法的健康风险与益处,你应该了解的内容。
Menopause. 2013 Nov;20(11):e5. doi: 10.1097/GME.0b013e31829cd3a9.
9
Hormone replacement therapy in postmenopausal women.绝经后女性的激素替代疗法。
Minerva Endocrinol. 2005 Mar;30(1):27-36.
10
Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?乳腺癌女性的激素替代疗法。风险是否大于益处?
J Clin Oncol. 1996 Mar;14(3):997-1006. doi: 10.1200/JCO.1996.14.3.997.

引用本文的文献

1
Estrogen and neuroprotection: from clinical observations to molecular mechanisms.雌激素与神经保护:从临床观察到分子机制
Dialogues Clin Neurosci. 2002 Jun;4(2):149-61. doi: 10.31887/DCNS.2002.4.2/ddubal.